` Comparison: LCTX, PNEXF - Alpha Spread

L
LCTX
vs
PNEXF

Over the past 12 months, LCTX has significantly outperformed PNEXF, delivering a return of +156% compared to the PNEXF's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
LCTX
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

LCTX Intrinsic Value
HIDDEN
Show
PNEXF Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
L
Lineage Cell Therapeutics Inc
TASE:LCTX
531.7 ILS
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
LCTX, PNEXF

LCTX
PNEXF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
L
Lineage Cell Therapeutics Inc
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
LCTX, PNEXF

LCTX
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
L
Lineage Cell Therapeutics Inc
TASE:LCTX
Pharnext SCA
OTC:PNEXF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

LCTX
97.6%
PNEXF
0%

Operating Margin

LCTX
-186.9%
PNEXF
-17 526.7%

Net Margin

LCTX
-374.8%
PNEXF
-21 040%

FCF Margin

LCTX
-212.1%
PNEXF
-15 953.3%

ROE

LCTX
-70.1%
PNEXF
114.6%

ROA

LCTX
-42.3%
PNEXF
-391.1%

ROIC

LCTX
-37.5%
PNEXF
3 092.9%

ROCE

LCTX
-24.3%
PNEXF
275.4%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
LCTX, PNEXF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
LCTX, PNEXF

Performance Gap Between LCTX and PNEXF
HIDDEN
Show

Performance By Year
LCTX, PNEXF

Loading
LCTX
PNEXF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare LCTX to other stocks
Unlock Full Access to Alpha Spread
Create Free Account